Journal Search Engine
Search Advanced Search Adode Reader(link)
Download PDF Export Citaion korean bibliography PMC previewer
ISSN : 1225-1577(Print)
ISSN : 2384-0900(Online)
The Korean Journal of Oral and Maxillofacial Pathology Vol.42 No.5 pp.135-143
DOI : https://doi.org/10.17779/KAOMP.2018.42.5.005

Undifferentiated Pleomorphic Sarcoma in the Mandibular Ramus and Post-Operative Recurrence: A Case Report

Jaemyung Ahn1), Seung-Il Jang2), Jongrak Hong3), Jun Young Paeng4)*
Department of Oral and Maxillofacial Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine
Department of Oral and Maxillofacial Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine
Department of Oral and Maxillofacial Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine
Department of Oral and Maxillofacial Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine
Correspondence: Jun Young Paeng, Department of Oral and
Maxillofacial Surgery, Samsung Medical Center, Sungkyunkwan
University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul
06351, Republic of Korea, Tel: 82-2-3410-2420, Fax: 82-2-3410-0038 E-mail: jypaeng@gmail.com
September 19, 2018 September 28, 2018 October 19, 2018

Abstract


Undifferentiated pleomorphic sarcoma (UPS) in the mandible region is a rare malignant neoplasm. We encountered the case of a patient who had been diagnosed with deep benign fibrous histiocytoma (DBFH) prior to surgery, but the final biopsy revealed the presence of tumor tissues in the resected margin, which indicated a UPS. Therefore, radiotherapy was conducted post-operatively, but the tumor recurred approximately 3 years later and a second surgery was performed. The difference between the initial and final diagnoses was considered to be due to the characteristics of the tumor, as it involved both benign and malignant components. DBFH and UPS can occur in young women. DBFH can transform to a malignancy and UPS may also appear as a benign tumor during early biopsy. Hence, attention should be paid to diagnosis and treatment methods, and ongoing close observation is required.



하악지 영역에 발생한 미분화성 다형성 육종: 수술 후 재발한 증례

안 재명1), 장 승일2), 홍 종락3), 팽 준영4)*
성균관대학교 의과대학 삼성서울병원 구강악안면외과
성균관대학교 의과대학 삼성서울병원 구강악안면외과
성균관대학교 의과대학 삼성서울병원 구강악안면외과
성균관대학교 의과대학 삼성서울병원 구강악안면외과

초록


    Ⅰ. INTRODUCTION

    Fibrous histiocytoma is characterized as a mixed proliferation of fibroblast-like and histiocyte-like cells, rarely showing characteristics of malignant tumors, in which case it is referred to as a malignant fibrous histiocytoma (MFH) [1]. The term MFH has recently been changed to undifferentiated pleomorphic sarcoma (UPS) as it exhibits similar morphologic patterns to those of other types of sarcoma [2]. UPS has been reported to occur in the limbs and in the retroperitoneum, and the incidence of UPS in the mandible has been reported to comprise 3% of all UPS cases [3]. UPS in the mandible is common among men aged between 50 and 79, and clinical symptoms include pain that has spread over a period of several weeks or months. UPS that invades hard tissue in the head and neck region exhibit considerably more aggressive characteristics than UPS localized to the soft tissues [4]. In general, UPS has a poor prognosis, since it exhibits chemoresistance as a high-grade sarcoma occurring in soft and hard tissues, and also exhibits a high metastatic potential [5]. However, previous studies have shown that UPS in the mandible has a more favorable prognosis due to smaller size and lower grade compared with UPS in the trunk and extremities [6]. Here, we report on the case of a patient diagnosed with a DBFH following a pre-operative incisional biopsy performed on a tumor that had developed in the right mandible area. The diagnosis was then changed to a UPS, based on post-operative biopsy results, and the patient underwent follow-up radiation therapy, and a second operation due to recurrence. This study analyzes the treatment process, progress, and characteristics from the time of diagnosis to recurrence.

    Ⅱ. CASE REPORT

    This case report was reviewed by the Institutional Review Board (IRB) of Samsung Medical Center and was approved from deliberation (SMC 2018-06-047). Written informed consent was obtained from the patient for publication of this case report and accompanying images. A 23-year-old Korean woman with no history of systemic disease visited a hospital due to masticatory pain present for three months in the right jaw and was admitted to the present institution in January 2015. On examination, no malocclusion was observed, and evaluation of the face revealed that the right facial area was noted to be slightly larger than the left side (Fig. 1A). Preoperative computed tomography (CT) scans showed medial cortical bone resorption in the right mandibular ramus, and expansion of the lateral cortical bone. A 5.3-cm sized malignant tumor with signs of invasion in most condyles was also found. Magnetic resonance imaging (MRI) (T2) showed a soft tissue tumor invading the nearby masticator and parotid space (Fig. 1B). An incisional biopsy was performed on lymph nodes within the soft and hard tissues of the lesion, submaxillary gland, and parotid gland, using a transparotid approach prior to surgery. Biopsy results showed no signs of malignancy, and the patient was diagnosed with a deep benign fibrous histiocytoma (DBFH) (Fig. 1C).

    Mass excision was performed on the benign tumor at the present institution in March, 2015, in addition to reconstruction of the ramus condyle unit using a costochondral graft. No significant changes to the face, functional loss, or complications occurred postoperatively (Figs. 2A, 2B).

    However, the patient was diagnosed with UPS (French Federation of Comprehensive Cancer Centers [FNCLCC] grade 2/3) based on the final biopsy results of the main mass postoperatively (Fig. 2C). A tumor was found around the specimen margin. Accordingly, 27 radiotherapy sessions were performed using a radiation dose of 64 Gy for the tumor margin, and a dose of 54 Gy for the tumor bed postoperatively. Positron emission tomography-computed tomography (PET-CT) scans obtained after the completion of radiotherapy showed reduced uptake in the condylar area (Fig. 3).

    From May 2015 to December 2017, no signs of recurrence were observed during this follow-up period. However, panoramic radiographs obtained in December 2017 showed patterns of bone resorption in the right condyle head. CT and PET examinations were performed accordingly, and signs of recurrence were observed (Fig. 4).

    The costal cartilage implanted on the existing reconstruction plate and the tumor were removed in January, 2018, and mandibular reconstruction using a scapular free flap was performed (Fig. 5A). The resected tumor was diagnosed as UPS (FNCLCC grade 2/3) based on biopsy results. Although there was premature contact in the left posterior molar region in the early postoperative period, the patient currently has stable occlusion. No recurrence or unusual signs in the lymph nodes and satisfactory bone healing at the graft site have been observed on CT scans obtained in May 2018, and the maximum mouth opening has been maintained at 30 mm (Figs. 5B,C).

    Ⅲ. DISCUSSION

    UPS, as its name suggests, is a soft mass sarcoma whose origin or differentiation cannot be defined, and which cannot be classified according to its site of occurrence [2]. UPS does not show clinical characteristics of other types of sarcoma, and exhibits widespread pleomorphism, and spindle cells in terms of histological characteristics, as well as poor tissue differentiation [7]. The characteristics of UPS are similar to those of metastatic carcinoma or melanoma [8], and it is morphologically similar to histiocytes or fibroblasts due to its elongated shape. DBFH is a benign fibrous histiocytoma that is usually observed in the subcutaneous tissues or deep soft tissues, and it almost never metastasizes to other tissues [9]. According to the World Health Organization classification, DBFH is a benign tumor belonging to a group of fibrohistiocytic tumors, and usually occurs in the upper and lower limbs, and rarely in the oral and maxillofacial area [10,11]. Its indolent nature and tendency to grow are characteristics similar to those of cysts, and its histological structure resembles that of a storiform pattern [12]. Similar characteristics were observed in the first biopsy performed in this study. The first biopsy, performed using the transparotid approach, showed no signs of malignancy or invasion into bone tissues from the lymph nodes within the soft tissue, submandibular duct tissues, and parotid gland. The characteristic DBFH storiform pattern was observed in the soft tissues and there were no unusual findings observed following immunohistochemical staining (Fig. 1C). Based on these results, the patient was diagnosed with DBFH, and surgery was performed. The resection site was limited to the benign tumor, which was the main reason for including the tumor in the resection margin. The tissue resected during the first surgery exhibited heterogeneity, showing various histological characteristics. In one region of the tumor, hyperchromatic multinucleated cells clustering in a storiform pattern were observed. In another part, cells with increased pleomorphism could be observed. These cells did not form a particular structure, and it was difficult to identify their origin histologically, suggesting the tumor had poor differentiation. In addition, tumor giant cells that are characteristically observed in malignant tumors could be observed. Immunohistological chemical staining gave negative results in most tests, indicating that the tumor had poor differentiation, and locating its origin would be difficult (Figs. 2C,D,E,F). According to the FNCLCC grading system, the tumor’s differentiation was graded as score 3, mitotic count as score 2, and tumor necrosis as score 0. The total score was 5, and the tumor was classified as Grade 2. In a UPS case reported by Kim et al. [13], tumor resection was performed in a 44-year old male patient with UPS that had occurred in the left mandible, followed by immunohistochemical staining of the resected tissue. The resected tissue showed reactivity to vimentin, unlike the tumor in the present study. While the origin of the tumor in this study could not be identified, it could be deduced that the aforementioned tumor originated from mesenchymal cells. A possible reason for the difference in the results of the first histological examination, and those of the final histological examination performed postoperatively, is that in the first examination, the tissue samples were collected from areas exhibiting some characteristics of a benign tumor only and, therefore, the results were considered to apply to the entire tumor. In a case report by Tanaka et al. [14], an 80-year-old male patient underwent an excisional biopsy for a tumor that had developed in the right mandible, and the patient was eventually diagnosed with a benign fibrous histiocytoma. However, a second surgery was performed due to recurrence 6 months postoperatively, and the patient was diagnosed with UPS after a final biopsy. The recurrent lesion showed reactivity to CD68, alpha-1-antitrypsin, alpha-1-antichymotrypsin, and vimentin. This supports the view that DBFH can change to UPS, and therefore, a lesion can demonstrate characteristics of both DBFH and UPS concurrently. In this study, the tumor was found to be included in the resection site after the first surgery, and radiotherapy was performed accordingly to reduce the risk of local recurrence, and prevent an increase in the extent of surgery [15]. It is controversial whether chemotherapy is necessary for UPS. In this study, chemotherapy was not undertaken as clear therapeutic benefits were difficult to determine. However, studies have recently reported that chemotherapy can be effective in the treatment of UPS [5, 16]. However, UPS recurred at the same site within three years post-treatment. In this study, the first surgery was performed conservatively, and the second surgery involved extensive resection of the lesion and surrounding tissues (Fig. 5A). The tumor showed even clearer characteristics of malignancy in the biopsy performed after the second surgery. Clear signs of bone invasion were observed on hematoxylin and eosin (H&E) staining slides, and the tumor exhibited abnormal mitosis and moderate pleomorphism (Figs. 5D,5E). Signs of tumor invasion in the mandibular cortical bone were observed, as well as invasion in the lateral pterygoid muscle. The tumor signs indicated a grade 2/3 tumor, using the FNCLCC grading system. No metastases in the lymph nodes were observed and the resection margin was clear. DBFH and UPS are both rarely located in the oral and maxillofacial area. Identification of UPS in the mandible is common among men over the aged of 50 years; however, it can also occur in young women. Often, DBFH can become malignant, and early histological examinations of UPS can exhibit signs of a benign tumor. Therefore, it is necessary to refer to medical images and clinical progress, as well as pay close attention to diagnosis and treatment methods, and thoroughly and consistently monitor the treatment process.

    Figure

    KAOMP-42-135_F1.gif

    Preoperative diagnostic images. (A) Initial clinical photographs: right mandible enlargement is observed without trismus or malocclusion. (B) Preoperative computed tomography (CT, left) and magnetic resonance imaging (MRI, right): malignantooking large soft tissue mass involving the right mandibular ramus and condyle, with adjacent masticator and parotid space invasion. (C) H&E and immunohistochemical staining in incisional biopsy: no evidence of malignancy.

    KAOMP-42-135_F2.gif

    Clinical images following the first surgery. (A) Postoperative photographs: no facial deformation or functional issues were noted. (B) 3D reconstruction image postoperatively: mass excision and ramus condyle unit reconstruction with costochondral graft. (C, D) The spindle cells are forming bundles. (E, F) Increased pleomorphism and tumor giant cells (arrowhead) are observed (H&E x200, x400).

    KAOMP-42-135_F3.gif

    Adjuvant radiotherapy. An increased uptake on the right side of the condyle was observed using positron emission tomography–computed tomography (PET-CT) images taken following the first surgery (left). After adjuvant radiotherapy, the uptake had decreased (right).

    KAOMP-42-135_F4.gif

    Recurrent tumor of the right mandibular condyle. In the right condyle area, approximately 2 cm of irregular enhancing soft - tissue lesion that was invisible in previous CT images, is observed. Interval increased F-18 fluorodeoxyglucose(FDG) uptake (SUVmax = 7.4) and extent of hypermetabolic lesion involving right mandible, probable recurrent malignant tissue (yellow arrow).

    KAOMP-42-135_F5.gif

    Second surgery. (A) Partial mandibulectomy and reconstruction with a scapular free flap was performed after tumor removal and costal cartilage with the reconstruction plate and surrounding tissues. (B) Second postoperative photographs, right mandible depression is observed with mild trismus (maximum mouth opening: 30 mm). (C) Successful bone healing between the grafted scapular and the mandible body. (D, E) More specific bone invasion patterns and abnormal mitosis was observed (H&E staining x100, x400)

    Table

    Reference

    1. VarmaP , WaliaS , ManglawatR : Benign fibrous histiocytoma . Indian J Ophthalmology.2014;62:464-467.
    2. JoVY , FletcherCD : WHO classification of soft tissue tumours: an update based on the 2013 (4th) ed . Pathology.2014;46:95-104.
    3. HuvosAG , HeilweilM , BretskySS : The pathology of malignant fibrous histiocytoma of bone. A study of 130 patients . Ame J Surg Pathol.1985;9:853-371.
    4. IguchiY , TakahashiH , YaoK , NakayamaM , NagaiH , OkamotoM : Malignant fibrous histiocytoma of the nasal cavity and paranasal sinuses: review of the last 30 years . Acta Oto-Laryngologica Supplementum.2002:75-78.
    5. PasqualiS , GronchiA : Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications . Therapeutic Advances in Medical Oncology2017;9:415-429.
    6. BoruckiRB , NeskeyDM , LentschEJ : Malignant fibrous histiocytoma: Database review suggests a favorable prognosis in the head and neck . Laryngoscope.2018;128:885-388.
    7. LambadePN , LambadeD , SahaTK , BandeCR , RamakrishanaA : Malignant fibrous histiocytoma: an uncommon sarcoma with pathological fracture of mandible . J Maxillofac Oral Surg.2015;14(Suppl 1):283-287.
    8. HelmKF : Malignant melanoma masquerading as malignant fibrous histiocytoma . Am J Dermatopathol.1997;19:473-476.
    9. CalonjeE , MentzelT , FletcherCD : Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence . Am J Surg Pathol.1994;18:668-676.
    10. FletcherCD : Benign fibrous histiocytoma of subcutaneous and deep soft tissue: a clinicopathologic analysis of 21 cases . Am J Surg Pathol.1990;14:801-809.
    11. GrayPB , MillerAS , LoftusMJ : Benign fibrous histiocytoma of the oral/perioral regions: report of a case and review of 17 additional cases . J Oral Maxillofac Surg.1992;50:1239-1242.
    12. AkbulutS , ArikanogluZ , BasbugM : Benign fibrous histiocytoma arising from the right shoulder: Is immunohistochemical staining always required for a definitive diagnosis? Inter J Surg.2012;3:287-289.
    13. KimCH , JangJW , KimMY , KimYH , KimHG , KimJH : Undifferentiated Pleomorphic Sarcoma in Mandible . Maxillofacial Plastic and Reconstructive Surgery.2014;36:303-307.
    14. TanakaT , KobayashiT , IinoM . Transformation of benign fibrous histiocytoma into malignant fibrous histiocytoma in the mandible: case report . J Oral Maxillofac Surg.2011;69:e285-90.
    15. LarrierNA , CzitoBG , KirschDG : Radiation Therapy for Soft Tissue Sarcoma: Indications and Controversies for Neoadjuvant Therapy, Adjuvant Therapy, Intraoperative Radiation Therapy, and Brachytherapy.2016;25:841-860.
    16. MovvaS , von MehrenM , RossEA , HandorfE . Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival . J National Comprehensive Cancer Network.2015;13:1366-1374.
    오늘하루 팝업창 안보기 닫기